» Articles » PMID: 8796897

Liposomes As Delivery Agents for Medical Imaging

Overview
Journal Mol Med Today
Date 1996 Jun 1
PMID 8796897
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Medical imaging requires an appropriate intensity of signal from the area of interest in order to differentiate certain structures from surrounding tissues, regardless of the modality used. In the majority of cases, contrast agents specific for each imaging modality are necessary to achieve a sufficiently intense signal. To facilitate the accumulation of contrast in the required zone, various microparticulates have been suggested as carriers for contrast agents. Among these carriers, liposomes-microscopic artificial phospholipid vesicles-draw special attention because of their easily controlled properties and useful pharmacological characteristics. This review will discuss how the advantages of liposomes have been used so far in the rapidly growing field of diagnostic medical imaging.

Citing Articles

Nanoparticle Contrast Agents for Photon-Counting Computed Tomography: Recent Developments and Future Opportunities.

Devkota L, Bhavane R, Badea C, Tanifum E, Annapragada A, Ghaghada K Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025; 17(1):e70004.

PMID: 39948059 PMC: 11874078. DOI: 10.1002/wnan.70004.


Metal-Organic Frameworks for Overcoming the Blood-Brain Barrier in the Treatment of Brain Diseases: A Review.

Nabipour H, Rohani S Nanomaterials (Basel). 2024; 14(17).

PMID: 39269041 PMC: 11397546. DOI: 10.3390/nano14171379.


Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology.

Ashoub M, Razavi R, Heydaryan K, Salavati-Niasari M, Amiri M Eur J Med Res. 2024; 29(1):224.

PMID: 38594732 PMC: 11003188. DOI: 10.1186/s40001-024-01822-7.


Advances in nanoprobes for molecular MRI of Alzheimer's disease.

Parekh P, Badachhape A, Tanifum E, Annapragada A, Ghaghada K Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(2):e1946.

PMID: 38426638 PMC: 10983770. DOI: 10.1002/wnan.1946.


Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials.

Xu M, Han X, Xiong H, Gao Y, Xu B, Zhu G Molecules. 2023; 28(13).

PMID: 37446806 PMC: 10343932. DOI: 10.3390/molecules28135145.